Anirvan Ghosh - 31 Mar 2022 Form 4 Insider Report for Unity Biotechnology, Inc. (UBX)

Role
Chief Executive Officer, Director
Signature
/s/ Alexander Nguyen, Attorney-in-Fact for Anirvan Ghosh
Issuer symbol
UBX
Transactions as of
31 Mar 2022
Net transactions value
-$16,498
Form type
4
Filing time
01 Apr 2022, 16:24:48 UTC
Previous filing
15 Mar 2022
Next filing
03 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction UBX Common Stock, $0.0001 par value Tax liability $16,498 -14,472 -1.4% $1.14 1,039,923 31 Mar 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold by the Reporting Person pursuant to a Rule 10b5-1 trading instruction to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units.
F2 Includes Restricted Stock Units which vest over time measured from the grant date.